Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2007 Dec 7

PMID 18057246

Citations 63

Authors

Minetaro Arita

Yasushi Ami

Takaji Wakita

Hiroyuki Shimizu

Affiliations

Soon will be listed here.

Abstract

Enterovirus 71 (EV71) is a causative agent of hand, foot, and mouth disease and is also associated with serious neurological disorders. An attenuated EV71 strain [EV71(S1-3')] has been established in the cynomolgus monkey infection model; this strain contains the attenuation determinants derived from the type 1 poliovirus vaccine strain, Sabin 1 [PV1(Sabin)], in the 5' nontranslated region (NTR), 3D polymerase, and 3' NTR. In this study, we analyzed the effect of the attenuation determinants of PV1(Sabin) on EV71 infection in a NOD/SCID mouse infection model. We isolated a mouse-adapted EV71 strain [EV71(NOD/SCID)] that causes paralysis of the hind limbs in 3- to 4-week-old NOD/SCID mice by adaptation of the virulent EV71(Nagoya) strain in the brains of NOD/SCID mice. A single mutation at nucleotide 2876 that caused an amino acid change in capsid protein VP1 (change of the glycine at position 145 to glutamic acid) was essential for the mouse-adapted phenotype in NOD/SCID mice. Next, we introduced attenuation determinants derived from PV1(Sabin) along with the mouse adaptation mutation into the EV71(Nagoya) genome. In 4-week-old mice, the determinants in the 3D polymerase and 3' NTR, which are the major temperature-sensitive determinants, had a strong effect on attenuation. In contrast, the effect of individual determinants was weak in 3-week-old NOD/SCID mice, and all the determinants were required for substantial attenuation. These results suggest that a cooperative effect of the attenuation determinants of PV1(Sabin) is essential for attenuated neurovirulence of EV71.

Citing Articles

An efficient complementation system for replication of defective poliovirus mutants.

Arita M J Virol. 2024; 98(7):e0052324.

PMID: 38837378 PMC: 11265389. DOI: 10.1128/jvi.00523-24.

Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding.

Yan J, Wang M, Li X, Fan J, Yu R, Kang M Microbiol Spectr. 2024; 12(4):e0333223.

PMID: 38441464 PMC: 10986554. DOI: 10.1128/spectrum.03332-23.

Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.

Weng K, Tee H, Tseligka E, Cagno V, Mathez G, Rosset S Cell Rep. 2023; 42(4):112389.

PMID: 37058406 PMC: 10590055. DOI: 10.1016/j.celrep.2023.112389.

Murine models of neonatal susceptibility to a clinical strain of enterovirus A71.

Xie J, Hu X, Li H, Zhu H, Lin W, Li L Virus Res. 2023; 324:199038.

PMID: 36599394 PMC: 10194309. DOI: 10.1016/j.virusres.2022.199038.

Genetic and Cross Neutralization Analyses of Coxsackievirus A16 Circulating in Taiwan from 1998 to 2021 Suggest Dominant Genotype B1 can Serve as Vaccine Candidate.

Cheng D, Chiu Y, Huang S, Lien Y, Chang C, Tsai H Viruses. 2022; 14(10).

PMID: 36298861 PMC: 9608817. DOI: 10.3390/v14102306.

References

SCHMIDT N, LENNETTE E, Ho H . An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974; 129(3):304-9. DOI: 10.1093/infdis/129.3.304. View

Nijhuis M, van Maarseveen N, Schuurman R, Verkuijlen S, de Vos M, Hendriksen K . Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol. 2002; 40(10):3666-70. PMC: 130891. DOI: 10.1128/JCM.40.10.3666-3670.2002. View

Wu T, Wang Y, Lee Y, Wang J, Liu C, Wang S . Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol. 2007; 81(19):10310-5. PMC: 2045469. DOI: 10.1128/JVI.00372-07. View

Hashimoto I, Hagiwara A . Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection. Neuropathol Appl Neurobiol. 1982; 8(2):149-56. DOI: 10.1111/j.1365-2990.1982.tb00269.x. View

Chen C, Yao Y, Lin S, Lee Y, Wang Y, Wang J . Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007; 81(17):8996-9003. PMC: 1951457. DOI: 10.1128/JVI.00236-07. View

Paul A, Mugavero J, Yin J, Hobson S, Schultz S, VAN Boom J . Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Virology. 2000; 272(1):72-84. DOI: 10.1006/viro.2000.0354. View

Smyth M, Tate J, Hoey E, Lyons C, Martin S, Stuart D . Implications for viral uncoating from the structure of bovine enterovirus. Nat Struct Biol. 1995; 2(3):224-31. DOI: 10.1038/nsb0395-224. View

Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y . Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002; 67(2):207-16. DOI: 10.1002/jmv.2209. View

CHUMAKOV M, Voroshilova M, SHINDAROV L, Lavrova I, Gracheva L, Koroleva G . Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979; 60(3-4):329-40. DOI: 10.1007/BF01317504. View

10.

Liu C, Lian W, Butler M, Wu S . High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine. 2006; 25(1):19-24. DOI: 10.1016/j.vaccine.2006.06.083. View

11.

Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T . The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005; 79(7):4460-9. PMC: 1061561. DOI: 10.1128/JVI.79.7.4460-4469.2005. View

12.

La Monica N, Almond J, Racaniello V . A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol. 1987; 61(9):2917-20. PMC: 255821. DOI: 10.1128/JVI.61.9.2917-2920.1987. View

13.

Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K . Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 1983; 32(3):247-53. DOI: 10.2337/diab.32.3.247. View

14.

Bouchard M, Lam D, Racaniello V . Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol. 1995; 69(8):4972-8. PMC: 189313. DOI: 10.1128/JVI.69.8.4972-4978.1995. View

15.

Kauder S, Racaniello V . Poliovirus tropism and attenuation are determined after internal ribosome entry. J Clin Invest. 2004; 113(12):1743-53. PMC: 420511. DOI: 10.1172/JCI21323. View

16.

LUM L, Wong K, Lam S, Chua K, Goh A, Lim W . Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998; 133(6):795-8. DOI: 10.1016/s0022-3476(98)70155-6. View

17.

Harvala H, Kalimo H, Bergelson J, Stanway G, Hyypia T . Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J Gen Virol. 2005; 86(Pt 7):1897-1907. DOI: 10.1099/vir.0.80603-0. View

18.

Wang S, Liu C, Tseng H, Wang J, Huang C, Chen Y . Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999; 29(1):184-90. DOI: 10.1086/520149. View

19.

Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N . The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 1990; 9(10):3217-24. PMC: 552052. DOI: 10.1002/j.1460-2075.1990.tb07520.x. View

20.

Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H . Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A. 1991; 88(3):951-5. PMC: 50932. DOI: 10.1073/pnas.88.3.951. View